Ulvmoen A, Greiff V, Bechensteen A, Inngjerdingen M. NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia. J Leukoc Biol. 2024;115:334-343 pubmed publisher

Huuhtanen J, Kasanen H, Peltola K, L xf6 nnberg T, Glumoff V, Br xfc ck O, et al. Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma. J Clin Invest. 2023;133: pubmed publisher

Fernandez R, Mayoral J, Pierre Louis L, Yao Y, Xu Y, Mu S, et al. Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15. Blood Adv. 2023;7:9-19 pubmed publisher

Palamarchuk A, Alekseeva N, Streltsova M, Ustiuzhanina M, Kobyzeva P, Kust S, et al. Increased Susceptibility of the CD57- NK Cells Expressing KIR2DL2/3 and NKG2C to iCasp9 Gene Retroviral Transduction and the Relationships with Proliferative Potential, Activation Degree, and Death Induction Response. Int J Mol Sci. 2021;22: pubmed publisher

Nagano S, Maeda T, Ichise H, Kashima S, Ohtaka M, Nakanishi M, et al. High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells. Mol Ther Methods Clin Dev. 2020;16:126-135 pubmed publisher

Calabrese D, Chong T, Wang A, Singer J, Gottschall M, Hays S, et al. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients. Transplantation. 2019;103:493-501 pubmed publisher

Nuñez S, Ziblat A, Secchiari F, Torres N, Sierra J, Raffo Iraolagoitia X, et al. Human M2 Macrophages Limit NK Cell Effector Functions through Secretion of TGF-? and Engagement of CD85j. J Immunol. 2018;200:1008-1015 pubmed publisher

Rechtien A, Richert L, Lorenzo H, Martrus G, Hejblum B, Dahlke C, et al. Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV. Cell Rep. 2017;20:2251-2261 pubmed publisher

Kovalenko E, Streltsova M, Kanevskiy L, Erokhina S, Telford W. Identification of Human Memory-Like NK Cells. Curr Protoc Cytom. 2017;79:9.50.1-9.50.11 pubmed publisher

Sim M, Stowell J, Sergeant R, Altmann D, Long E, Boyton R. KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells. Eur J Immunol. 2016;46:185-91 pubmed publisher

Spallanzani R, Torres N, Avila D, Ziblat A, Iraolagoitia X, Rossi L, et al. Regulatory Dendritic Cells Restrain NK Cell IFN-γ Production through Mechanisms Involving NKp46, IL-10, and MHC Class I-Specific Inhibitory Receptors. J Immunol. 2015;195:2141-8 pubmed publisher

Dunphy S, Guinan K, Chorcora C, Jayaraman J, Traherne J, Trowsdale J, et al. 2DL1, 2DL2 and 2DL3 all contribute to KIR phenotype variability on human NK cells. Genes Immun. 2015;16:301-10 pubmed publisher

Katano I, Takahashi T, Ito R, Kamisako T, Mizusawa T, Ka Y, et al. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse. J Immunol. 2015;194:3513-25 pubmed publisher

Charoudeh H, Terszowski G, Czaja K, Gonzalez A, Schmitter K, Stern M. Modulation of the natural killer cell KIR repertoire by cytomegalovirus infection. Eur J Immunol. 2013;43:480-7 pubmed publisher